glp 1 v ozempic GLP-1 Agonists for Weight Loss: A Side-by-Side Comparison GLP-1 vs Ozempic vs Wegovy

Biochem Soc Symp

GLP-1 medications, bariatric surgery, peptide therapy, and other medical weight loss treatments require evaluation by a licensed healthcare provider

Diabetes Care (2013) 36(3):498504

By addressing underlying issues such as inflammation and insulin resistance, these medications can transform lives

Clarifying these pathways may guide preventive or therapeutic strategies and improve patient quality of life

Eight major RCTs of GLP-1RAs have investigated the cardiovascular outcomes, including the ELIXA trial of lixisenatide (250), the EXSCEL trial of exenatide ER (251), the LEARDER trial of liraglutide (252), the SUSTAIN-6 trial of subcutaneous semaglutide (253), the HARMONY trial of albiglutide (228), the REWIND trial of dulaglutide (254), the PIONEER trial of oral semaglutide (255), and the SELECT trial of subcutaneous semaglutide (199)